Published Date: 13 Mar 2023
Some adults do not consider the importance of testing, while others believe that a healthy diet with regular bowel movements does not require testing, according to the study.
Read Full NewsNeurologists Michael Levy, MD, PhD, and Fu-Dong Shi, MD, PhD, discuss the rationale, design, and clinical implications of the phase 3 DAWN trial evaluating daratumumab in aquaporin-4–positive NMOSD.
Ava L. Liberman, MD, assistant professor of clinical neurology at Weill Cornell Medicine, shared key takeaways from stroke data presented at the 2026 International Stroke Conference.
ACP urged to drop “provider” for physicians, warning it blurs expertise, commodifies care, and erodes professional identity, trust, and the patient relationship.
Phase 3 DAWN data show daratumumab cuts NMOSD relapse risk 76%, stays well tolerated, and may improve disability, signaling a new targeted option.
Siegel addressed additional points presented in his Maui Derm 2026 session, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'
7 Pulmonology Headlines You Missed in January 2026
1.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
2.
Obesity-related cancers are more likely in people who are obese in both healthy and unhealthy ways.
3.
According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.
4.
An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.
5.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
1.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
2.
The Complications and Treatments of Intraosseous Hemangioma - A Comprehensive Guide
3.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
4.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
5.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation